Insulin glargine/Liraglutide

N/A

Report date: 2026/04/07 20:00:20

Base Information

Drug NameInsulin glargine/Liraglutide
Drug Alias NameN/A
ClassificationBiologics > Protein drugs
Mechanisms of ActionInsulin receptor agonistsGlucagon-like peptide 1 receptor agonists
TargetsInsulin receptorGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsYes Insulin glargineLiraglutide
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdocia
China Registration ClassN/A

Develop Information

Active CompaniesAdocia
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A